Find out more about our continuing education presentations below and email [email protected] to schedule a presentation.
Presented by Nicole Bennett, DVM, MS, DACVIM
This course provides a practical, evidence-based guide to integrating SGLT2 inhibitors, an exciting new oral medication for feline diabetes, into clinical practice. Participants will learn how this approach can simplify treatment for owners, moving away from stressful daily insulin injections, and leading to a more normalized client-cat relationship. Key topics include patient selection, contraindications, and comprehensive monitoring for cats on SGLT2 therapy. This program is ideal for practitioners seeking to offer innovative, non-injectable options for managing diabetic patients.